Literature DB >> 30632770

Using probiotics for type 2 diabetes mellitus intervention: Advances, questions, and potential.

Zhongke Sun1,2, Xuejiao Sun1,3, Juan Li1, Zhaoyang Li1, Qingwei Hu4, Lili Li1, Xinqi Hao2, Maoping Song2, Chengwei Li1,5.   

Abstract

Type 2 diabetes mellitus (T2DM) has become one of the most prevalent diseases on earth and several treatments have been developed. However, the current intervention approaches have not been as effective as expected. One promising supplementary strategy is the use of probiotics through direct or indirect approaches. Probiotics are microbial food cultures conferring health-promoting properties. In this review, we summarized the current theories and mechanisms of T2DM intervention using probiotics and hypothesize that probiotics intervene T2DM during its onsetting, developing, and complicating. For the first time, we comprehensively analyzed T2DM intervention in animal models using both wide-type probiotics in different forms and using recombinant probiotics. Then, probiotic intervention in T2DM patients was reviewed and the main results were compared with that obtained from animal studies. Finally yet importantly, remaining questions that are important such as in which form and in which state, as well as the future potential of probiotic intervention in T2DM were discussed from a perspective of food microbiologists. In conclusion, probiotic intervention in T2DM is promising but there are still many important issues unsolved yet. Critical review of the advances, questions, and potential of probiotic intervention in T2DM promotes the development of this approach for further application in humans.

Entities:  

Keywords:  Probiotics; diabetes mellitus; glucose; immunity; insulin

Mesh:

Year:  2019        PMID: 30632770     DOI: 10.1080/10408398.2018.1547268

Source DB:  PubMed          Journal:  Crit Rev Food Sci Nutr        ISSN: 1040-8398            Impact factor:   11.176


  12 in total

Review 1.  Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications.

Authors:  Lili Zhang; Jinjin Chu; Wenhao Hao; Jiaojiao Zhang; Haibo Li; Chunjuan Yang; Jinghan Yang; Xiaohua Chen; Honggang Wang
Journal:  Mediators Inflamm       Date:  2021-08-17       Impact factor: 4.711

Review 2.  Probiotics, their prophylactic and therapeutic applications in human health development: A review of the literature.

Authors:  Bantayehu Addis Tegegne; Bekalu Kebede
Journal:  Heliyon       Date:  2022-06-22

3.  Analysis of Intestinal Short-Chain Fatty Acid Metabolism Profile After Probiotics and GLP-1 Treatment for Type 2 Diabetes Mellitus.

Authors:  Qiuxia Min; Yan Wang; TaiCheng Jin; Lei Zhu; XianYan Wu; YiKun Li; YanJiao Wang; Ning Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-30       Impact factor: 6.055

4.  Effects of an Iranian traditional fermented food consumption on blood glucose, blood pressure, and lipid profile in type 2 diabetes: a randomized controlled clinical trial.

Authors:  Sayed Omid Salehi; Farzad Karimpour; Hossein Imani; Mohammad Amin Ghatee; Mohammad Pirouze; Tooba Bahramfard
Journal:  Eur J Nutr       Date:  2022-05-05       Impact factor: 4.865

Review 5.  Gastrointestinal Disorders and Metabolic Syndrome: Dysbiosis as a Key Link and Common Bioactive Dietary Components Useful for their Treatment.

Authors:  Anna De Filippis; Hammad Ullah; Alessandra Baldi; Marco Dacrema; Cristina Esposito; Emanuele Ugo Garzarella; Cristina Santarcangelo; Ariyawan Tantipongpiradet; Maria Daglia
Journal:  Int J Mol Sci       Date:  2020-07-13       Impact factor: 5.923

Review 6.  Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds.

Authors:  Xin Nie; Zhejie Chen; Lan Pang; Lin Wang; Huajuan Jiang; Yi Chen; Zhen Zhang; Chaomei Fu; Bo Ren; Jinming Zhang
Journal:  Int J Nanomedicine       Date:  2020-12-16

7.  Nutritional Effects of the Enteral Nutritional Formula on Regulation of Gut Microbiota and Metabolic Level in Type 2 Diabetes Mellitus Mice.

Authors:  Ting Wei; Ye Jia; Wei Xue; Ming Ma; Wenhui Wu
Journal:  Diabetes Metab Syndr Obes       Date:  2021-04-28       Impact factor: 3.168

8.  Angiotensin-(1-7) Expressed From Lactobacillus Bacteria Protect Diabetic Retina in Mice.

Authors:  Amrisha Verma; Ping Zhu; Kang Xu; Tao Du; Shengquan Liao; Zhibing Liang; Mohan K Raizada; Qiuhong Li
Journal:  Transl Vis Sci Technol       Date:  2020-12-14       Impact factor: 3.283

9.  Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation.

Authors:  Fanny Perraudeau; Paul McMurdie; James Bullard; Andrew Cheng; Colleen Cutcliffe; Achal Deo; John Eid; Jessica Gines; Mohan Iyer; Nicholas Justice; Wesley T Loo; Madeleine Nemchek; Marcus Schicklberger; Michael Souza; Brendon Stoneburner; Surabhi Tyagi; Orville Kolterman
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07

10.  Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 decrease glycemic levels and attenuate diabetes-mediated liver and kidney injury in db/db mice.

Authors:  Pei-Shan Hsieh; Hsieh-Hsun Ho; Shih-Hung Hsieh; Yi-Wei Kuo; Hsiu-Ying Tseng; Hui-Fang Kao; Jiu-Yao Wang
Journal:  BMJ Open Diabetes Res Care       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.